""	"Name"	"Genes (tot)"	"Stat (dist.dir.up)"	"p (dist.dir.up)"	"p adj (dist.dir.up)"	"Stat (dist.dir.dn)"	"p (dist.dir.dn)"	"p adj (dist.dir.dn)"	"Stat (non-dir.)"	"p (non-dir.)"	"p adj (non-dir.)"	"Genes (up)"	"Stat (mix.dir.up)"	"p (mix.dir.up)"	"p adj (mix.dir.up)"	"Genes (down)"	"Stat (mix.dir.dn)"	"p (mix.dir.dn)"	"p adj (mix.dir.dn)"
"1"	"ABC transporters"	11	1.9225	0.12535	0.84962	-1.9225	0.87465	1	-11.614	0.88104	0.99991	5	-1.7295	0.26124	0.99991	6	-14.146	0.98503	0.99894
"2"	"AGE-RAGE signaling pathway in diabetic complications"	39	-0.28274	0.74683	1	0.28274	0.25317	0.43413	-13.97	0.55766	0.99991	14	-4.9474	0.31808	0.99991	25	-13.746	0.71596	0.94563
"3"	"AMPK signaling pathway"	56	-1.1648	0.92819	1	1.1648	0.071814	0.16295	-15.008	0.41579	0.91549	21	-9.2805	0.53403	0.99991	35	-11.795	0.32105	0.6656
"4"	"Acute myeloid leukemia"	28	-1.9643	0.97232	1	1.9643	0.027677	0.087932	-16.54	0.9074	0.99991	9	-9.6505	0.8188	0.99991	19	-13.437	0.81389	0.9829
"5"	"Adherens junction"	32	-0.8189	0.8516	1	0.8189	0.1484	0.29013	-12.504	0.55755	0.99991	15	-11.437	0.81624	0.99991	17	-6.4127	0.22132	0.66099
"6"	"Adipocytokine signaling pathway"	31	1.0968	0.36286	1	-1.0968	0.63714	0.82857	-15.768	0.80733	0.99991	17	-10.059	0.66478	0.99991	14	-12.379	0.83804	0.9829
"7"	"Adrenergic signaling in cardiomyocytes"	57	-4.6857	0.99997	1	4.6857	3.2161e-05	0.0018432	-10.674	0.085532	0.46584	14	-4.7196	0.30001	0.99991	43	-9.5966	0.085579	0.51269
"8"	"African trypanosomiasis"	14	-1.7114	0.94855	1	1.7114	0.051453	0.13413	-4.0046	0.16475	0.68832	4	-4.4422	0.54077	0.99991	10	-1.9288	0.080952	0.51269
"9"	"Alanine, aspartate and glutamate metabolism"	16	5.8163	2.4792e-05	0.00039798	-5.8163	0.99998	1	-0.85871	0.039495	0.33461	13	1.3381	0.030586	0.43985	3	-4.7687	0.55951	0.82115
"10"	"Alcoholism"	29	-3.0935	0.9967	1	3.0935	0.0032965	0.020519	-10.187	0.36225	0.8762	11	-14.076	0.95409	0.99991	18	-1.9261	0.024936	0.41391
"11"	"Aldosterone synthesis and secretion"	24	-2.5297	0.98927	1	2.5297	0.010733	0.044845	-7.3643	0.23313	0.76949	7	-5.3648	0.50786	0.99991	17	-5.3076	0.14817	0.58527
"12"	"Aldosterone-regulated sodium reabsorption"	16	-0.064942	0.64202	1	0.064942	0.35798	0.57164	-10.428	0.67429	0.99991	6	-3.6802	0.39018	0.99991	10	-10.34	0.77717	0.9829
"13"	"Allograft rejection"	4	0.23723	0.51353	1	-0.23723	0.48647	0.68375	-9.4213	0.88512	0.99991	2	-6.021	0.758	0.99991	2	-7.3027	0.8608	0.9829
"14"	"Alzheimer disease"	113	23.334	0	0	-23.334	1	1	17.962	0	0	90	21.175	0	0	23	-2.0752	0.011246	0.41391
"15"	"Amino sugar and nucleotide sugar metabolism"	27	0.71999	0.4504	1	-0.71999	0.5496	0.74834	-4.7067	0.072219	0.44054	14	-0.63347	0.074243	0.69469	13	-6.1257	0.30166	0.6656
"16"	"Aminoacyl-tRNA biosynthesis"	21	7.3041	1.196e-07	2.6056e-06	-7.3041	1	1	-1.7724	0.026315	0.30869	20	-1.2361	0.045469	0.54927	1	-2.5943	0.52295	0.80744
"17"	"Amoebiasis"	42	-1.9885	0.98224	1	1.9885	0.017764	0.064167	-10.306	0.20611	0.74193	12	-4.1803	0.2879	0.99991	30	-9.5504	0.2143	0.66099
"18"	"Amphetamine addiction"	20	-4.1124	0.9998	1	4.1124	0.00020101	0.0042766	-2.1493	0.037167	0.33435	5	-3.2532	0.38207	0.99991	15	-0.60359	0.014616	0.41391
"19"	"Amyotrophic lateral sclerosis (ALS)"	21	-2.1201	0.97799	1	2.1201	0.022005	0.074573	-2.4338	0.037272	0.33435	7	-1.8874	0.22746	0.99991	14	-1.6462	0.046023	0.46466
"20"	"Antigen processing and presentation"	24	-0.14127	0.70965	1	0.14127	0.29035	0.48658	-8.6765	0.34118	0.86351	10	-2.5884	0.19525	0.99991	14	-9.1725	0.57476	0.8227
"21"	"Apelin signaling pathway"	54	-2.0258	0.98447	1	2.0258	0.015533	0.059221	-16.559	0.58256	0.99991	19	-9.582	0.6122	0.99991	35	-13.508	0.48249	0.80631
"22"	"Apoptosis"	49	-0.17783	0.76542	1	0.17783	0.23458	0.40883	-18.162	0.7858	0.99991	19	-10.525	0.68738	0.99991	30	-14.836	0.72489	0.94563
"23"	"Arachidonic acid metabolism"	15	0.64673	0.44586	1	-0.64673	0.55414	0.75117	-6.4112	0.35867	0.8757	8	-6.7366	0.61287	0.99991	7	-2.1834	0.15669	0.58657
"24"	"Arginine and proline metabolism"	27	5.4343	0.00023849	0.0031625	-5.4343	0.99976	1	-2.1005	0.019154	0.24341	21	-1.9591	0.057684	0.62217	6	-0.79056	0.1152	0.57666
"25"	"Arginine biosynthesis"	11	6.2579	5.4299e-06	0.00010351	-6.2579	0.99999	1	0.1204	0.041944	0.34191	11	0.1204	0.075909	0.69469	0			
"26"	"Arrhythmogenic right ventricular cardiomyopathy (ARVC)"	36	-4.5467	0.99991	1	4.5467	9.0559e-05	0.003069	-9.0227	0.17162	0.69793	12	-10.526	0.81494	0.99991	24	-3.6076	0.025204	0.41391
"27"	"Ascorbate and aldarate metabolism"	6	0.80463	0.33784	1	-0.80463	0.66216	0.85214	-1.9537	0.23283	0.76949	4	0.85452	0.14475	0.94545	2	-4.5925	0.65094	0.89658
"28"	"Asthma"	2	0.35063	0.43871	1	-0.35063	0.56129	0.75416	-6.021	0.75831	0.99991	2	-6.021	0.758	0.99991	0			
"29"	"Autoimmune thyroid disease"	4	0.23723	0.51353	1	-0.23723	0.48647	0.68375	-9.4213	0.88512	0.99991	2	-6.021	0.758	0.99991	2	-7.3027	0.8608	0.9829
"30"	"Autophagy"	56	-1.9648	0.97934	1	1.9648	0.02066	0.071605	-22.468	0.94757	0.99991	17	-12.386	0.82737	0.99991	39	-18.746	0.84873	0.9829
"31"	"Axon guidance"	55	-2.6688	0.99659	1	2.6688	0.0034126	0.020817	-20.32	0.85318	0.99991	22	-18.356	0.98034	0.99991	33	-11.245	0.32698	0.6656
"32"	"B cell receptor signaling pathway"	27	-3.5643	0.99834	1	3.5643	0.001658	0.016313	-16.205	0.89271	0.99991	6	-14.657	0.98844	0.99991	21	-10.54	0.50818	0.80631
"33"	"Bacterial invasion of epithelial cells"	42	-0.40055	0.81008	1	0.40055	0.18992	0.3532	-14.808	0.59141	0.99991	21	-13.049	0.82634	0.99991	21	-7.8921	0.25364	0.66099
"34"	"Basal cell carcinoma"	4	0.23573	0.51397	1	-0.23573	0.48603	0.68375	-12.49	0.97231	0.99991	2	-6.0534	0.76019	0.99991	2	-11.61	0.98574	0.99894
"35"	"Basal transcription factors"	4	-1.1579	0.85365	1	1.1579	0.14635	0.28798	-7.5482	0.77776	0.99991	2	-11.61	0.97197	0.99991	2	0.9352	0.1511	0.58527
"36"	"Base excision repair"	8	-1.1412	0.84708	1	1.1412	0.15292	0.29333	-14.084	0.97613	0.99991	1	-8.2095	0.91769	0.99991	7	-11.953	0.92942	0.9829
"37"	"Bile secretion"	15	-0.95855	0.8494	1	0.95855	0.1506	0.29256	-8.186	0.52068	0.99991	6	-4.5854	0.47267	0.99991	9	-6.8241	0.47511	0.80631
"38"	"Biosynthesis of unsaturated fatty acids"	11	1.3555	0.23469	1	-1.3555	0.76531	0.93368	-4.0021	0.2399	0.7784	7	-3.3569	0.33609	0.99991	4	-2.1961	0.27674	0.6656
"39"	"Bladder cancer"	12	-1.4205	0.9024	1	1.4205	0.097602	0.20673	-10.305	0.7523	0.99991	3	-6.5093	0.76789	0.99991	9	-8.1414	0.60923	0.8574
"40"	"Breast cancer"	22	-1.5087	0.94077	1	1.5087	0.059227	0.14444	-17.651	0.96291	0.99991	7	-10.615	0.88056	0.99991	15	-14.125	0.90502	0.9829
"41"	"Butanoate metabolism"	16	5.7459	3.1052e-05	0.00047354	-5.7459	0.99997	1	-3.6568	0.13332	0.59796	16	-3.6568	0.1641	0.97174	0			
"42"	"C-type lectin receptor signaling pathway"	33	-3.353	0.99813	1	3.353	0.0018747	0.017087	-16.264	0.84385	0.99991	7	-10.691	0.88383	0.99991	26	-12.777	0.61253	0.8574
"43"	"Calcium signaling pathway"	51	-2.8415	0.99712	1	2.8415	0.0028832	0.020133	-4.5768	0.0056183	0.090189	17	-1.4374	0.067425	0.67875	34	-4.589	0.013855	0.41391
"44"	"Carbohydrate digestion and absorption"	12	-0.65926	0.77004	1	0.65926	0.22996	0.4031	-6.3969	0.39	0.90731	4	-0.047973	0.19454	0.99991	8	-7.8006	0.63316	0.87622
"45"	"Cardiac muscle contraction"	41	9.9097	9.8316e-12	2.4989e-10	-9.9097	1	1	5.6147	3.208e-06	9.7843e-05	29	10.919	6.5658e-07	2.2032e-05	12	-6.5952	0.36707	0.70516
"46"	"Cell adhesion molecules (CAMs)"	24	0.39309	0.56413	1	-0.39309	0.43587	0.65167	-22.168	0.99798	0.99991	11	-10.34	0.80652	0.99991	13	-20.609	0.99894	0.99894
"47"	"Cell cycle"	32	-1.7586	0.96058	1	1.7586	0.039423	0.1077	-24.542	0.99901	0.99991	10	-23.231	0.99991	0.99991	22	-13.937	0.793	0.9829
"48"	"Cellular senescence"	49	-1.1205	0.92203	1	1.1205	0.077975	0.17234	-11.657	0.21684	0.74998	19	-6.0902	0.31983	0.99991	30	-10.051	0.25461	0.66099
"49"	"Central carbon metabolism in cancer"	33	0.33266	0.58024	1	-0.33266	0.41976	0.63214	-9.9045	0.30101	0.84807	14	-6.8257	0.48009	0.99991	19	-7.194	0.24072	0.66099
"50"	"Chagas disease (American trypanosomiasis)"	33	-3.2656	0.99771	1	3.2656	0.0022946	0.017945	-17.709	0.91281	0.99991	9	-15.422	0.98708	0.99991	24	-11.321	0.50777	0.80631
"51"	"Chemical carcinogenesis"	21	1.9846	0.1328	0.86182	-1.9846	0.8672	1	-3.4719	0.061721	0.43907	11	0.26167	0.071573	0.69469	10	-5.3057	0.29772	0.6656
"52"	"Chemokine signaling pathway"	50	-2.4048	0.99223	1	2.4048	0.0077657	0.035364	-23.429	0.97235	0.99991	18	-18.999	0.99258	0.99991	32	-15.038	0.68697	0.92868
"53"	"Cholesterol metabolism"	21	-0.12563	0.68952	1	0.12563	0.31048	0.50913	-3.7219	0.069168	0.43951	10	-3.8679	0.28336	0.99991	11	-1.4546	0.059452	0.46466
"54"	"Choline metabolism in cancer"	35	-1.5049	0.94108	1	1.5049	0.05892	0.14444	-16.023	0.79162	0.99991	15	-15.395	0.96224	0.99991	20	-7.8645	0.27509	0.6656
"55"	"Cholinergic synapse"	30	-2.6056	0.98997	1	2.6056	0.010026	0.04247	-12.46	0.57912	0.99991	9	-9.2282	0.79228	0.99991	21	-8.8508	0.33884	0.68235
"56"	"Chronic myeloid leukemia"	30	-2.4312	0.98613	1	2.4312	0.013875	0.054958	-19.158	0.96369	0.99991	9	-17.543	0.99667	0.99991	21	-11.413	0.59708	0.85047
"57"	"Circadian entrainment"	29	-3.2803	0.99785	1	3.2803	0.0021466	0.017695	-8.9426	0.2594	0.78983	10	-9.0845	0.72322	0.99991	19	-4.4574	0.080203	0.51269
"58"	"Circadian rhythm"	9	1.0154	0.28175	1	-1.0154	0.71825	0.89782	-5.5802	0.43223	0.91549	6	-3.4291	0.36799	0.99991	3	-4.8156	0.564	0.82115
"59"	"Citrate cycle (TCA cycle)"	29	15.221	0	0	-15.221	1	1	11.376	2.8603e-08	1.0905e-06	27	11.872	5.0569e-07	1.909e-05	2	-0.30034	0.23748	0.66099
"60"	"Cocaine addiction"	10	-1.1707	0.86169	1	1.1707	0.13831	0.27754	-5.3696	0.37177	0.8762	4	-1.5524	0.29758	0.99991	6	-5.6647	0.51221	0.80631
"61"	"Collecting duct acid secretion"	11	-1.7659	0.94706	1	1.7659	0.05294	0.13569	-3.0765	0.17462	0.70076	2	-1.7042	0.40703	0.99991	9	-2.5978	0.12456	0.58527
"62"	"Colorectal cancer"	31	-1.1239	0.89621	1	1.1239	0.10379	0.21832	-17.52	0.89828	0.99991	10	-8.5788	0.68419	0.99991	21	-15.367	0.8973	0.9829
"63"	"Complement and coagulation cascades"	38	-4.0895	0.99977	1	4.0895	0.00023001	0.0042766	-10.874	0.28653	0.83657	3	-3.9014	0.55399	0.99991	35	-10.189	0.19511	0.64522
"64"	"Cortisol synthesis and secretion"	9	-2.4312	0.97702	1	2.4312	0.02298	0.07702	-2.9903	0.21885	0.74998	2	-4.7242	0.66239	0.99991	7	-0.8655	0.089688	0.52378
"65"	"Cushing syndrome"	33	-1.4507	0.93409	1	1.4507	0.065907	0.15345	-13.891	0.66953	0.99991	13	-8.833	0.68345	0.99991	20	-10.721	0.54858	0.82115
"66"	"Cysteine and methionine metabolism"	29	5.0839	0.00037644	0.0047839	-5.0839	0.99962	1	-0.25345	0.0035698	0.060489	19	2.0124	0.013345	0.23708	10	-3.2056	0.14217	0.58527
"67"	"Cytokine-cytokine receptor interaction"	3	0.082069	0.54847	1	-0.082069	0.45153	0.66303	-10.178	0.94951	0.99991	1	-1.2105	0.43418	0.99991	2	-11.61	0.98574	0.99894
"68"	"Cytosolic DNA-sensing pathway"	11	0.33633	0.51624	1	-0.33633	0.48376	0.68375	-19.972	0.99943	0.99991	6	-13.481	0.97715	0.99991	5	-14.855	0.99347	0.99894
"69"	"D-Glutamine and D-glutamate metabolism"	3	1.7799	0.13051	0.86182	-1.7799	0.86949	1	-2.7672	0.4245	0.91549	2	-3.3186	0.54558	0.99991	1	-0.099624	0.28646	0.6656
"70"	"DNA replication"	9	0.15317	0.52637	1	-0.15317	0.47363	0.68375	-10.115	0.8131	0.99991	3	-7.7756	0.84646	0.99991	6	-6.8903	0.63302	0.87622
"71"	"Dilated cardiomyopathy (DCM)"	45	-4.921	0.99996	1	4.921	3.6259e-05	0.0018432	-6.3702	0.031046	0.3121	14	-6.5618	0.45645	0.99991	31	-3.2654	0.0079846	0.41391
"72"	"Dopaminergic synapse"	46	-4.8903	0.99999	1	4.8903	8.9708e-06	0.00068403	-10.482	0.18279	0.70604	11	-10.429	0.81183	0.99991	35	-6.17	0.032429	0.41749
"73"	"Drug metabolism"	38	0.90832	0.46835	1	-0.90832	0.53165	0.73042	-11.852	0.37059	0.8762	19	-8.2141	0.496	0.99991	19	-8.5468	0.36014	0.69643
"74"	"ECM-receptor interaction"	38	-0.80504	0.87467	1	0.80504	0.12533	0.25485	-9.8647	0.21055	0.74193	16	-8.6639	0.56495	0.99991	22	-5.5762	0.084563	0.51269
"75"	"Endocrine and other factor-regulated calcium reabsorption"	21	-1.9164	0.96847	1	1.9164	0.031526	0.092457	-9.6157	0.45875	0.94539	5	-6.8719	0.69365	0.99991	16	-7.1747	0.31717	0.6656
"76"	"Endocytosis"	125	-2.5431	0.99684	1	2.5431	0.0031575	0.020133	-24.503	0.55941	0.99991	40	-15.545	0.80631	0.99991	85	-19.051	0.27501	0.6656
"77"	"Endometrial cancer"	20	-1.9886	0.97197	1	1.9886	0.028029	0.088123	-12.554	0.75897	0.99991	5	-5.3231	0.56401	0.99991	15	-11.423	0.73004	0.94743
"78"	"Epithelial cell signaling in Helicobacter pylori infection"	30	-1.4732	0.93532	1	1.4732	0.064682	0.15259	-16.956	0.89808	0.99991	12	-13.415	0.94051	0.99991	18	-10.936	0.61216	0.8574
"79"	"Epstein-Barr virus infection"	74	-1.54	0.97296	1	1.54	0.027035	0.08746	-30.866	0.9984	0.99991	23	-23.53	0.99959	0.99991	51	-21.378	0.88952	0.9829
"80"	"ErbB signaling pathway"	39	-1.9473	0.96936	1	1.9473	0.030644	0.091631	-17.665	0.84798	0.99991	14	-11.931	0.86439	0.99991	25	-13.135	0.66175	0.90295
"81"	"Estrogen signaling pathway"	34	-2.8024	0.99314	1	2.8024	0.0068641	0.033231	-10.862	0.35889	0.8757	11	-7.227	0.57186	0.99991	23	-8.2083	0.22335	0.66099
"82"	"Ether lipid metabolism"	10	-1.0873	0.8476	1	1.0873	0.1524	0.29333	-12.7	0.91598	0.99991	3	-9.8059	0.93129	0.99991	7	-8.7596	0.74568	0.96344
"83"	"Fanconi anemia pathway"	5	-1.0518	0.82108	1	1.0518	0.17892	0.33896	-7.2767	0.73364	0.99991	1	-8.2095	0.91769	0.99991	4	-4.0308	0.4504	0.80631
"84"	"Fat digestion and absorption"	9	0.61752	0.38952	1	-0.61752	0.61048	0.80604	-4.4061	0.3281	0.84807	6	-5.9859	0.60133	0.99991	3	0.83376	0.11343	0.57666
"85"	"Fatty acid biosynthesis"	7	2.9881	0.022365	0.21317	-2.9881	0.97763	1	-1.0949	0.12478	0.57664	5	-1.2336	0.22663	0.99991	2	-0.097917	0.22171	0.66099
"86"	"Fatty acid degradation"	32	8.1624	3.7014e-09	8.6841e-08	-8.1624	1	1	-0.40127	0.0024128	0.043289	26	0.7277	0.0087393	0.16495	6	-2.4415	0.2169	0.66099
"87"	"Fatty acid elongation"	15	4.2823	0.0026687	0.030147	-4.2823	0.99733	1	1.2153	0.016156	0.21424	11	2.7434	0.022246	0.36043	4	-2.1961	0.27674	0.6656
"88"	"Fc epsilon RI signaling pathway"	27	-1.9118	0.96045	1	1.9118	0.039549	0.1077	-14.202	0.77953	0.99991	11	-13.874	0.94965	0.99991	16	-6.9457	0.29761	0.6656
"89"	"Fc gamma R-mediated phagocytosis"	41	-0.85694	0.87076	1	0.85694	0.12924	0.26104	-14.353	0.55848	0.99991	17	-11.429	0.76753	0.99991	24	-9.1414	0.29495	0.6656
"90"	"Ferroptosis"	21	0.11892	0.62102	1	-0.11892	0.37898	0.59291	-5.7274	0.15553	0.66814	10	-7.2367	0.57129	0.99991	11	-1.0136	0.047354	0.46466
"91"	"Fluid shear stress and atherosclerosis"	58	-1.0696	0.92553	1	1.0696	0.074467	0.167	-19.876	0.82019	0.99991	24	-10.945	0.65533	0.99991	34	-16.764	0.78742	0.9829
"92"	"Focal adhesion"	101	-2.7025	0.99828	1	2.7025	0.0017227	0.016419	-19.074	0.288	0.83657	39	-15.765	0.80714	0.99991	62	-11.841	0.060469	0.46466
"93"	"Folate biosynthesis"	11	2.1212	0.097213	0.74125	-2.1212	0.90279	1	-0.59517	0.06043	0.43907	7	-0.53696	0.14799	0.94545	4	-0.27665	0.13962	0.58527
"94"	"FoxO signaling pathway"	42	-1.7558	0.97276	1	1.7558	0.027242	0.08746	-14.583	0.57095	0.99991	13	-8.2536	0.6344	0.99991	29	-12.024	0.4673	0.80631
"95"	"Fructose and mannose metabolism"	21	-1.6056	0.9476	1	1.6056	0.0524	0.13544	-3.5704	0.064577	0.43907	7	0.65441	0.095458	0.77739	14	-4.8356	0.18649	0.64065
"96"	"GABAergic synapse"	19	-2.3082	0.98098	1	2.3082	0.019016	0.067441	-7.2049	0.29484	0.84043	7	-8.8877	0.78719	0.99991	12	-2.2779	0.078315	0.51269
"97"	"Galactose metabolism"	15	0.46262	0.49923	1	-0.46262	0.50077	0.69742	-1.7906	0.074997	0.44851	9	-1.2952	0.15937	0.96259	6	-1.2449	0.13903	0.58527
"98"	"Gap junction"	28	-1.7538	0.96087	1	1.7538	0.039134	0.1077	-10.988	0.47876	0.95439	12	-8.997	0.7073	0.99991	16	-6.7444	0.28088	0.6656
"99"	"Gastric acid secretion"	23	-2.7178	0.99075	1	2.7178	0.0092503	0.040251	-2.8758	0.030955	0.3121	7	-2.8528	0.29656	0.99991	16	-1.5609	0.032884	0.41749
"100"	"Gastric cancer"	29	-1.2557	0.91131	1	1.2557	0.088687	0.19321	-22.015	0.99248	0.99991	10	-12.128	0.89837	0.99991	19	-18.4	0.98466	0.99894
"101"	"Glioma"	25	-2.1046	0.97169	1	2.1046	0.028315	0.088123	-13.432	0.74608	0.99991	8	-9.184	0.79774	0.99991	17	-9.9885	0.55056	0.82115
"102"	"Glucagon signaling pathway"	49	-1.8109	0.97306	1	1.8109	0.02694	0.08746	-9.6267	0.10127	0.51478	19	-7.5298	0.43737	0.99991	30	-6.3108	0.050192	0.46466
"103"	"Glutamatergic synapse"	27	-3.9678	0.99937	1	3.9678	0.00062956	0.008728	-6.5071	0.14996	0.65338	10	-13.187	0.93433	0.99991	17	1.9133	0.0021771	0.3175
"104"	"Glutathione metabolism"	34	3.1846	0.026095	0.24118	-3.1846	0.97391	1	-4.7699	0.031722	0.3121	19	0.12844	0.035178	0.46191	15	-7.3259	0.32824	0.6656
"105"	"Glycerolipid metabolism"	20	0.83856	0.39868	1	-0.83856	0.60132	0.79741	-5.257	0.14881	0.65338	11	-3.0348	0.22967	0.99991	9	-4.4815	0.25251	0.66099
"106"	"Glycerophospholipid metabolism"	29	-0.49229	0.78251	1	0.49229	0.21749	0.38791	-14.053	0.71143	0.99991	13	-12.718	0.91543	0.99991	16	-7.4554	0.34185	0.68329
"107"	"Glycine, serine and threonine metabolism"	17	2.9808	0.030201	0.26318	-2.9808	0.9698	1	-3.5639	0.11646	0.55499	11	-1.7511	0.1534	0.94545	6	-3.6279	0.31442	0.6656
"108"	"Glycolysis / Gluconeogenesis"	47	0.13244	0.68	1	-0.13244	0.32	0.52192	-0.052592	0.0003173	0.0069126	20	2.3886	0.0058951	0.12717	27	-2.1251	0.0043493	0.3175
"109"	"Glycosaminoglycan degradation"	5	1.1998	0.24257	1	-1.1998	0.75743	0.93152	-7.1407	0.72267	0.99991	5	-7.1407	0.71434	0.99991	0			
"110"	"Glycosphingolipid biosynthesis"	2	1.7861	0.11697	0.8297	-1.7861	0.88303	1	1.1336	0.16249	0.68832	2	1.1336	0.19769	0.99991	0			
"111"	"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"	4	-0.12156	0.6163	1	0.12156	0.3837	0.59708	-8.2815	0.82522	0.99991	1	-0.27213	0.35409	0.99991	3	-9.4055	0.89864	0.9829
"112"	"Glyoxylate and dicarboxylate metabolism"	23	10.06	7.3509e-12	2.0382e-10	-10.06	1	1	6.5726	1.0204e-05	0.00025936	19	7.1655	0.00043799	0.011023	4	0.14369	0.11717	0.57666
"113"	"GnRH signaling pathway"	33	-3.4826	0.99862	1	3.4826	0.0013797	0.014511	-9.8289	0.2947	0.84043	12	-11.012	0.84323	0.99991	21	-3.9968	0.047606	0.46466
"114"	"Graft-versus-host disease"	4	0.23723	0.51353	1	-0.23723	0.48647	0.68375	-9.4213	0.88512	0.99991	2	-6.021	0.758	0.99991	2	-7.3027	0.8608	0.9829
"115"	"HIF-1 signaling pathway"	51	-2.1897	0.98835	1	2.1897	0.011649	0.048015	-11.811	0.20586	0.74193	18	-8.3433	0.52578	0.99991	33	-8.5217	0.13233	0.58527
"116"	"Hedgehog signaling pathway"	9	-1.3354	0.88052	1	1.3354	0.11948	0.24623	-11.423	0.88399	0.99991	2	-7.4884	0.8456	0.99991	7	-8.95	0.76092	0.97881
"117"	"Hematopoietic cell lineage"	14	0.13262	0.58571	1	-0.13262	0.41429	0.62866	-11.53	0.80774	0.99991	6	-3.8412	0.40461	0.99991	8	-11.926	0.92217	0.9829
"118"	"Hepatitis B"	53	-1.6079	0.96332	1	1.6079	0.036681	0.10456	-22.506	0.9485	0.99991	18	-13.515	0.88795	0.99991	35	-18.003	0.85544	0.9829
"119"	"Hepatitis C"	50	-1.9842	0.98212	1	1.9842	0.017883	0.064167	-21.761	0.93715	0.99991	16	-17.713	0.987	0.99991	34	-14.238	0.56956	0.82115
"120"	"Hepatocellular carcinoma"	43	-1.0366	0.90609	1	1.0366	0.093915	0.20172	-18.193	0.85424	0.99991	19	-14.781	0.92022	0.99991	24	-11.2	0.49533	0.80631
"121"	"Herpes simplex virus 1 infection"	59	-1.168	0.9435	1	1.168	0.056501	0.14011	-26.606	0.99445	0.99991	21	-19.472	0.99171	0.99991	38	-18.677	0.88122	0.9829
"122"	"Hippo signaling pathway"	34	-2.0224	0.97064	1	2.0224	0.029358	0.089542	-19.138	0.95244	0.99991	11	-16.381	0.98582	0.99991	23	-11.94	0.56532	0.82115
"123"	"Histidine metabolism"	10	1.4451	0.19804	1	-1.4451	0.80196	0.9637	1.0727	0.033905	0.32316	8	0.72666	0.083704	0.72225	2	0.94527	0.15049	0.58527
"124"	"Homologous recombination"	8	-0.1594	0.62093	1	0.1594	0.37907	0.59291	-4.7672	0.40367	0.912	2	-3.7181	0.57966	0.99991	6	-3.358	0.29066	0.6656
"125"	"Human T-cell leukemia virus 1 infection"	61	-1.3004	0.94927	1	1.3004	0.05073	0.13339	-21.17	0.85604	0.99991	21	-11.165	0.69589	0.99991	40	-18.053	0.81093	0.9829
"126"	"Human cytomegalovirus infection"	77	-3.733	0.9998	1	3.733	0.00020436	0.0042766	-26.865	0.97933	0.99991	26	-24.882	0.99972	0.99991	51	-15.244	0.38603	0.72257
"127"	"Human immunodeficiency virus 1 infection"	80	-3.5281	0.99966	1	3.5281	0.00034049	0.0057694	-25.018	0.92978	0.99991	23	-20.871	0.99679	0.99991	57	-16.381	0.37297	0.7118
"128"	"Human papillomavirus infection"	110	-2.1186	0.99285	1	2.1186	0.0071535	0.034091	-34.806	0.99885	0.99991	42	-26.872	0.9993	0.99991	68	-23.15	0.85279	0.9829
"129"	"Huntington disease"	113	27.182	0	0	-27.182	1	1	14.211	0	0	96	19.439	0	0	17	-9.5557	0.50748	0.80631
"130"	"Hypertrophic cardiomyopathy (HCM)"	48	-3.0378	0.99717	1	3.0378	0.002833	0.020133	-9.1784	0.085011	0.46584	20	-8.6715	0.50312	0.99991	28	-4.6885	0.029915	0.41596
"131"	"IL-17 signaling pathway"	25	-2.0845	0.97072	1	2.0845	0.029285	0.089542	-19.696	0.98667	0.99991	7	-14.129	0.97458	0.99991	18	-14.4	0.87461	0.9829
"132"	"Inflammatory bowel disease (IBD)"	8	-0.21515	0.6363	1	0.21515	0.3637	0.57776	-8.6855	0.75532	0.99991	4	-4.6166	0.55591	0.99991	4	-7.6666	0.78889	0.9829
"133"	"Inflammatory mediator regulation of TRP channels"	29	-2.8225	0.99405	1	2.8225	0.0059502	0.03129	-10.313	0.37346	0.8762	9	-10.786	0.87904	0.99991	20	-5.1826	0.10151	0.54073
"134"	"Influenza A"	56	0.17297	0.69003	1	-0.17297	0.30997	0.50913	-17.541	0.65918	0.99991	24	-7.6646	0.36683	0.99991	32	-16.567	0.80738	0.9829
"135"	"Inositol phosphate metabolism"	24	-0.96996	0.87669	1	0.96996	0.12331	0.25241	-15.736	0.90469	0.99991	7	-7.458	0.68488	0.99991	17	-13.911	0.86621	0.9829
"136"	"Insulin resistance"	53	-0.60373	0.85636	1	0.60373	0.14364	0.28635	-20.096	0.85599	0.99991	21	-11.467	0.71943	0.99991	32	-16.573	0.80782	0.9829
"137"	"Insulin secretion"	22	-2.6365	0.99244	1	2.6365	0.0075614	0.035364	-7.998	0.31268	0.84807	6	-6.085	0.6102	0.99991	16	-5.6522	0.19887	0.64522
"138"	"Insulin signaling pathway"	77	-2.5234	0.99572	1	2.5234	0.0042815	0.024183	-24.037	0.91165	0.99991	29	-18.982	0.9766	0.99991	48	-15.69	0.47566	0.80631
"139"	"Intestinal immune network for IgA production"	2	0.35063	0.43871	1	-0.35063	0.56129	0.75416	-6.021	0.75831	0.99991	2	-6.021	0.758	0.99991	0			
"140"	"JAK-STAT signaling pathway"	18	-1.6909	0.93496	1	1.6909	0.06504	0.15259	-14.05	0.88505	0.99991	5	-7.2781	0.72465	0.99991	13	-12.019	0.82684	0.9829
"141"	"Kaposi sarcoma-associated herpesvirus infection"	59	-2.8584	0.99804	1	2.8584	0.0019608	0.017087	-23.506	0.96312	0.99991	20	-18.9	0.99046	0.99991	39	-15.377	0.57087	0.82115
"142"	"Legionellosis"	23	0.21279	0.60524	1	-0.21279	0.39476	0.60703	-3.3035	0.039324	0.33461	9	1.8258	0.043661	0.54927	14	-5.6981	0.24944	0.66099
"143"	"Leishmaniasis"	15	-0.61774	0.78391	1	0.61774	0.21609	0.38768	-12.828	0.87166	0.99991	9	-11.902	0.92289	0.99991	6	-5.7059	0.51636	0.80631
"144"	"Leukocyte transendothelial migration"	50	-1.3226	0.94476	1	1.3226	0.055237	0.13809	-16.702	0.64184	0.99991	25	-13.746	0.83338	0.99991	25	-9.874	0.34398	0.68329
"145"	"Linoleic acid metabolism"	3	-0.37883	0.67723	1	0.37883	0.32277	0.52365	-9.4965	0.92945	0.99991	2	-11.61	0.97197	0.99991	1	-0.029408	0.28053	0.6656
"146"	"Long-term depression"	24	-3.12	0.99685	1	3.12	0.0031519	0.020133	-7.3845	0.23463	0.76949	9	-9.9561	0.8366	0.99991	15	-1.6288	0.027704	0.41596
"147"	"Long-term potentiation"	29	-4.4172	0.99989	1	4.4172	0.00010698	0.0032628	-5.0629	0.059577	0.43907	6	-4.0595	0.42436	0.99991	23	-3.6116	0.028656	0.41596
"148"	"Longevity regulating pathway"	44	0.49793	0.57926	1	-0.49793	0.42074	0.63214	-20.251	0.92298	0.99991	22	-13.513	0.83715	0.99991	22	-15.126	0.87048	0.9829
"149"	"Lysine degradation"	22	6.164	6.9616e-06	0.0001249	-6.164	0.99999	1	-0.12945	0.0096005	0.13944	18	0.94022	0.022676	0.36043	4	-2.2981	0.28552	0.6656
"150"	"Lysosome"	41	1.8795	0.19428	1	-1.8795	0.80572	0.9637	-20.548	0.94437	0.99991	23	-13.341	0.83352	0.99991	18	-15.932	0.93703	0.98422
"151"	"MAPK signaling pathway"	80	-4.1965	0.99995	1	4.1965	4.9894e-05	0.0019681	-22.537	0.80366	0.99991	29	-18.062	0.9623	0.99991	51	-14.607	0.32743	0.6656
"152"	"Malaria"	13	-0.50734	0.74664	1	0.50734	0.25336	0.43413	-9.6676	0.68201	0.99991	4	-4.4583	0.54217	0.99991	9	-8.6468	0.65824	0.90237
"153"	"Mannose type O-glycan biosynthesis"	1	0	0.55636	1	0	0.44364	0.65684	-8.2095	0.93051	0.99991	0				1	-8.2095	0.92732	0.9829
"154"	"Maturity onset diabetes of the young"	1	0	0.55636	1	0	0.44364	0.65684	-8.2095	0.93051	0.99991	0				1	-8.2095	0.92732	0.9829
"155"	"Measles"	40	-0.41598	0.79526	1	0.41598	0.20474	0.37393	-20.608	0.95056	0.99991	14	-11.565	0.8456	0.99991	26	-17.075	0.91842	0.9829
"156"	"Melanogenesis"	23	-2.4471	0.98471	1	2.4471	0.015289	0.059221	-8.8872	0.36537	0.8762	8	-6.7911	0.61753	0.99991	15	-6.0453	0.21906	0.66099
"157"	"Melanoma"	14	-1.5045	0.92952	1	1.5045	0.070482	0.16286	-13.401	0.90797	0.99991	4	-9.742	0.897	0.99991	10	-9.6953	0.72474	0.94563
"158"	"Metabolism of xenobiotics by cytochrome P450"	19	1.2954	0.28868	1	-1.2954	0.71132	0.89649	-4.2756	0.10649	0.53247	10	-3.1839	0.23402	0.99991	9	-2.8562	0.13878	0.58527
"159"	"MicroRNAs in cancer"	43	-2.5173	0.99223	1	2.5173	0.0077685	0.035364	-23.602	0.99032	0.99991	16	-22.47	0.99953	0.99991	27	-12.488	0.52578	0.80744
"160"	"Mineral absorption"	12	0.33714	0.50427	1	-0.33714	0.49573	0.69356	-5.6802	0.32435	0.84807	6	-3.6749	0.38971	0.99991	6	-4.358	0.38243	0.72045
"161"	"Mismatch repair"	7	0.30519	0.49475	1	-0.30519	0.50525	0.70045	-8.1373	0.70275	0.99991	2	-3.7181	0.57966	0.99991	5	-7.2767	0.70366	0.93822
"162"	"Mitophagy"	33	-0.44157	0.77901	1	0.44157	0.22099	0.38961	-15.722	0.81052	0.99991	10	-5.7165	0.43647	0.99991	23	-15.063	0.82615	0.9829
"163"	"Morphine addiction"	14	-1.9277	0.96382	1	1.9277	0.036183	0.10411	-7.3646	0.43981	0.91877	6	-10.239	0.89342	0.99991	8	-0.87523	0.070491	0.51269
"164"	"Mucin type O-glycan biosynthesis"	1	0.13722	0.51694	1	-0.13722	0.48306	0.68375	-1.2311	0.42846	0.91549	1	-1.2311	0.43598	0.99991	0			
"165"	"N-Glycan biosynthesis"	13	-1.6233	0.92787	1	1.6233	0.072126	0.16295	-10.965	0.78321	0.99991	4	-8.5818	0.8438	0.99991	9	-7.4571	0.54015	0.82115
"166"	"NF-kappa B signaling pathway"	20	-1.5852	0.94535	1	1.5852	0.05465	0.13781	-19.477	0.99082	0.99991	5	-14.445	0.98586	0.99991	15	-14.15	0.90611	0.9829
"167"	"NOD-like receptor signaling pathway"	50	0.34533	0.62801	1	-0.34533	0.37199	0.58786	-19.272	0.83067	0.99991	24	-11.808	0.72387	0.99991	26	-15.381	0.83089	0.9829
"168"	"Natural killer cell mediated cytotoxicity"	27	-3.4284	0.99774	1	3.4284	0.0022578	0.017945	-11.762	0.57833	0.99991	8	-10.507	0.8706	0.99991	19	-7.2037	0.24149	0.66099
"169"	"Necroptosis"	58	0.36634	0.64703	1	-0.36634	0.35297	0.56661	-13.486	0.25943	0.78983	26	-7.6708	0.3209	0.99991	32	-11.242	0.32336	0.6656
"170"	"Neomycin, kanamycin and gentamicin biosynthesis"	2	1.0241	0.26099	1	-1.0241	0.73901	0.91625	0.10492	0.22905	0.76949	2	0.10492	0.26531	0.99991	0			
"171"	"Neuroactive ligand-receptor interaction"	9	-2.2307	0.96756	1	2.2307	0.03244	0.094229	-4.5759	0.34257	0.86351	2	-11.61	0.97197	0.99991	7	1.0172	0.034339	0.41779
"172"	"Neurotrophin signaling pathway"	48	-3.3661	0.99868	1	3.3661	0.0013234	0.014416	-19.161	0.83652	0.99991	13	-14.9	0.96987	0.99991	35	-13.358	0.46784	0.80631
"173"	"Nicotinate and nicotinamide metabolism"	18	2.2233	0.095368	0.74125	-2.2233	0.90463	1	-13.893	0.8777	0.99991	10	-7.7193	0.61312	0.99991	8	-12.209	0.93241	0.9829
"174"	"Nitrogen metabolism"	7	1.3347	0.21818	1	-1.3347	0.78182	0.95001	0.37172	0.066541	0.43907	2	3.5936	0.083369	0.72225	5	-1.8329	0.19388	0.64522
"175"	"Non-alcoholic fatty liver disease (NAFLD)"	96	24.042	0	0	-24.042	1	1	9.347	1.1768e-14	5.9823e-13	79	18.671	0	0	17	-18.038	0.98387	0.99894
"176"	"Non-homologous end-joining"	5	-1.8806	0.9351	1	1.8806	0.064902	0.15259	-2.8512	0.32572	0.84807	1	-8.2095	0.91769	0.99991	4	0.91704	0.082803	0.51269
"177"	"Non-small cell lung cancer"	23	-1.7199	0.94994	1	1.7199	0.050057	0.13276	-12.326	0.70093	0.99991	9	-11.149	0.89491	0.99991	14	-6.8599	0.34935	0.68463
"178"	"Notch signaling pathway"	6	-0.47281	0.70126	1	0.47281	0.29874	0.49519	-16.478	0.9967	0.99991	5	-18.357	0.99891	0.99991	1	0.68458	0.2239	0.66099
"179"	"Nucleotide excision repair"	11	-1.9445	0.96002	1	1.9445	0.039984	0.10792	-9.3876	0.73512	0.99991	1	-8.2095	0.91769	0.99991	10	-7.2497	0.48746	0.80631
"180"	"Olfactory transduction"	11	-2.7468	0.99068	1	2.7468	0.0093238	0.040251	-7.5438	0.56802	0.99991	3	-9.2136	0.91151	0.99991	8	-3.2038	0.19414	0.64522
"181"	"One carbon pool by folate"	11	1.1455	0.28569	1	-1.1455	0.71431	0.89656	-8.0808	0.6196	0.99991	6	-0.25991	0.14153	0.94545	5	-11.701	0.95271	0.99
"182"	"Oocyte meiosis"	41	-5.4937	1	1	5.4937	3.3068e-06	0.00033619	-8.0717	0.093642	0.4991	5	-8.5074	0.80802	0.99991	36	-5.4435	0.01246	0.41391
"183"	"Osteoclast differentiation"	32	-3.1317	0.99745	1	3.1317	0.0025488	0.019435	-19.02	0.95907	0.99991	12	-17.857	0.99503	0.99991	20	-10.226	0.49898	0.80631
"184"	"Other glycan degradation"	6	0.13861	0.52992	1	-0.13861	0.47008	0.68375	-5.643	0.55793	0.99991	3	-3.8142	0.5461	0.99991	3	-4.1662	0.50147	0.80631
"185"	"Other types of O-glycan biosynthesis"	4	-0.097364	0.60954	1	0.097364	0.39046	0.60452	-3.0968	0.39267	0.90731	1	1.2895	0.23535	0.99991	3	-4.3203	0.51637	0.80631
"186"	"Ovarian steroidogenesis"	9	-0.81237	0.78438	1	0.81237	0.21562	0.38768	-9.2978	0.75751	0.99991	3	-8.151	0.86589	0.99991	6	-5.6238	0.5081	0.80631
"187"	"Oxidative phosphorylation"	93	28.877	0	0	-28.877	1	1	24.633	0	0	83	27.629	0	0	10	-4.478	0.22855	0.66099
"188"	"Oxytocin signaling pathway"	63	-5.4256	1	1	5.4256	2.5436e-06	0.00033619	-11.241	0.096222	0.4991	16	-8.7924	0.57645	0.99991	47	-7.8846	0.02543	0.41391
"189"	"PI3K-Akt signaling pathway"	101	-2.3891	0.99643	1	2.3891	0.0035728	0.021367	-28.017	0.94754	0.99991	41	-23.921	0.99586	0.99991	60	-16.577	0.38004	0.72045
"190"	"PPAR signaling pathway"	35	3.5544	0.022326	0.21317	-3.5544	0.97767	1	-6.1619	0.06766	0.43907	24	-4.5652	0.1493	0.94545	11	-4.2481	0.1971	0.64522
"191"	"Pancreatic cancer"	31	-1.1046	0.89367	1	1.1046	0.10633	0.22213	-19.345	0.9547	0.99991	11	-10.969	0.84213	0.99991	20	-15.95	0.92493	0.9829
"192"	"Pancreatic secretion"	23	-1.877	0.96048	1	1.877	0.039525	0.1077	-9.479	0.423	0.91549	7	-3.7303	0.36663	0.99991	16	-8.8976	0.4773	0.80631
"193"	"Pantothenate and CoA biosynthesis"	8	0.60028	0.40279	1	-0.60028	0.59721	0.79541	-7.9156	0.69412	0.99991	6	-9.7101	0.86907	0.99991	2	0.98721	0.14799	0.58527
"194"	"Parathyroid hormone synthesis, secretion and action"	23	-2.0292	0.96889	1	2.0292	0.031109	0.092118	-13.522	0.7967	0.99991	7	-10.404	0.87102	0.99991	16	-9.3303	0.51924	0.80648
"195"	"Parkinson disease"	98	29.153	0	0	-29.153	1	1	22.743	0	0	88	26.578	0	0	10	-7.647	0.52816	0.80744
"196"	"Pathogenic Escherichia coli infection"	33	0.074739	0.65217	1	-0.074739	0.34783	0.56132	-11.273	0.42396	0.91549	17	-10.585	0.70629	0.99991	16	-5.2798	0.17459	0.63042
"197"	"Pathways in cancer"	140	-2.236	0.99475	1	2.236	0.0052464	0.028574	-30.744	0.90605	0.99991	56	-22.059	0.95661	0.99991	84	-21.679	0.55222	0.82115
"198"	"Pentose and glucuronate interconversions"	7	2.1753	0.080303	0.68034	-2.1753	0.9197	1	0.22166	0.0713	0.44054	4	1.9255	0.097818	0.77739	3	-1.8847	0.29136	0.6656
"199"	"Pentose phosphate pathway"	22	-4.0201	0.99976	1	4.0201	0.00023746	0.0042766	-7.2255	0.25136	0.78983	2	-6.4399	0.78542	0.99991	20	-5.5416	0.11849	0.57666
"200"	"Peroxisome"	42	5.7266	6.0271e-05	0.00083558	-5.7266	0.99994	1	-9.9898	0.1857	0.70604	31	-7.9485	0.26016	0.99991	11	-6.1768	0.35806	0.69643
"201"	"Pertussis"	28	-2.9455	0.99585	1	2.9455	0.004146	0.024069	-10.197	0.40142	0.912	6	-4.9213	0.50379	0.99991	22	-8.9337	0.31038	0.6656
"202"	"Phagosome"	59	-3.4035	0.99952	1	3.4035	0.00047751	0.0073541	-14.167	0.31733	0.84807	18	-12.815	0.85541	0.99991	41	-8.503	0.052556	0.46466
"203"	"Phenylalanine metabolism"	6	3.3875	0.009853	0.10363	-3.3875	0.99015	1	-0.33735	0.13285	0.59796	5	-0.49128	0.17999	0.99991	1	0.2722	0.25579	0.66099
"204"	"Phenylalanine, tyrosine and tryptophan biosynthesis"	2	5.8403	1.9248e-05	0.00032614	-5.8403	0.99998	1	5.6101	0.020744	0.25308	2	5.6101	0.034412	0.46191	0			
"205"	"Phosphatidylinositol signaling system"	28	-1.6349	0.95285	1	1.6349	0.047155	0.12616	-17.214	0.93218	0.99991	7	-10.39	0.87034	0.99991	21	-13.879	0.81116	0.9829
"206"	"Phospholipase D signaling pathway"	40	-3.7659	0.99952	1	3.7659	0.00048224	0.0073541	-13.411	0.48295	0.95649	13	-17.486	0.99336	0.99991	27	-4.1906	0.018406	0.41391
"207"	"Phosphonate and phosphinate metabolism"	2	0.85243	0.30278	1	-0.85243	0.69722	0.88237	2.9089	0.080398	0.45936	1	2.7227	0.1492	0.94545	1	1.3912	0.17488	0.63042
"208"	"Phototransduction"	2	-0.69941	0.72695	1	0.69941	0.27305	0.46176	-5.4795	0.71678	0.99991	1	-8.2095	0.91769	0.99991	1	0.46042	0.24095	0.66099
"209"	"Platelet activation"	53	-3.1284	0.99808	1	3.1284	0.0019227	0.017087	-15.517	0.49331	0.9707	16	-12.631	0.8572	0.99991	37	-10.266	0.17049	0.63015
"210"	"Porphyrin and chlorophyll metabolism"	18	2.2913	0.087325	0.71984	-2.2913	0.91268	1	-2.5638	0.065501	0.43907	10	2.3202	0.025278	0.3817	8	-6.4398	0.49366	0.80631
"211"	"Primary bile acid biosynthesis"	6	1.2059	0.23711	1	-1.2059	0.76289	0.93368	-2.8762	0.30478	0.84807	5	-3.1715	0.37516	0.99991	1	0.046521	0.2742	0.6656
"212"	"Primary immunodeficiency"	3	0.19465	0.51563	1	-0.19465	0.48437	0.68375	-9.8439	0.94032	0.99991	2	-6.2513	0.7733	0.99991	1	-8.2095	0.92732	0.9829
"213"	"Prion diseases"	21	-2.2796	0.98364	1	2.2796	0.016359	0.061599	-13.78	0.80791	0.99991	4	-2.3037	0.35696	0.99991	17	-14.198	0.88108	0.9829
"214"	"Progesterone-mediated oocyte maturation"	25	-2.3248	0.98065	1	2.3248	0.019345	0.067819	-14.869	0.84583	0.99991	5	-5.9673	0.61969	0.99991	20	-13.64	0.80435	0.9829
"215"	"Prolactin signaling pathway"	24	-2.3397	0.98464	1	2.3397	0.015362	0.059221	-12.689	0.71473	0.99991	7	-7.6485	0.69966	0.99991	17	-10.169	0.56834	0.82115
"216"	"Propanoate metabolism"	29	12.068	0	0	-12.068	1	1	5.5543	2.4838e-05	0.00058273	25	7.551	3.7512e-05	0.0010299	4	-3.922	0.43944	0.79699
"217"	"Prostate cancer"	30	-2.292	0.9822	1	2.292	0.017804	0.064167	-19.216	0.96479	0.99991	8	-10.58	0.87401	0.99991	22	-16.06	0.91519	0.9829
"218"	"Proteasome"	39	-3.1312	0.99683	1	3.1312	0.0031685	0.020133	-1.217	0.0018527	0.035317	6	1.5936	0.06628	0.67875	33	-2.0025	0.003341	0.3175
"219"	"Protein digestion and absorption"	26	1.0692	0.36159	1	-1.0692	0.63841	0.82857	-8.1559	0.25764	0.78983	14	-8.8604	0.65853	0.99991	12	-2.4348	0.084199	0.51269
"220"	"Protein export"	14	-0.36822	0.72597	1	0.36822	0.27403	0.46176	-4.7159	0.21163	0.74193	5	-6.5007	0.66404	0.99991	9	-1.0364	0.059952	0.46466
"221"	"Protein processing in endoplasmic reticulum"	97	-3.9167	0.99981	1	3.9167	0.00019261	0.0042766	-19.243	0.31895	0.84807	29	-14.441	0.82927	0.99991	68	-13.553	0.086034	0.51269
"222"	"Proteoglycans in cancer"	83	-4.5415	0.99995	1	4.5415	5.1621e-05	0.0019681	-17.014	0.26508	0.78983	27	-16.446	0.92116	0.99991	56	-9.2943	0.025515	0.41391
"223"	"Proximal tubule bicarbonate reclamation"	10	1.8827	0.12048	0.83513	-1.8827	0.87952	1	-1.1826	0.096548	0.4991	6	-1.3996	0.20935	0.99991	4	-0.15563	0.13287	0.58527
"224"	"Purine metabolism"	56	0.89281	0.4904	1	-0.89281	0.5096	0.7033	-13.34	0.26673	0.78983	25	-4.8571	0.13807	0.94545	31	-13.567	0.56008	0.82115
"225"	"Pyrimidine metabolism"	28	1.2673	0.31995	1	-1.2673	0.68005	0.86785	-18.346	0.9619	0.99991	13	-11.92	0.88307	0.99991	15	-13.969	0.898	0.9829
"226"	"Pyruvate metabolism"	34	6.6771	3.2145e-06	6.5362e-05	-6.6771	1	1	1.1259	0.00047895	0.0097386	22	3.9512	0.0018365	0.042663	12	-3.4547	0.13073	0.58527
"227"	"RIG-I-like receptor signaling pathway"	21	-0.79446	0.84232	1	0.79446	0.15768	0.30058	-19.213	0.98386	0.99991	10	-17.941	0.99493	0.99991	11	-9.4404	0.67823	0.92113
"228"	"RNA degradation"	36	-0.035685	0.70135	1	0.035685	0.29865	0.49519	-17.636	0.86267	0.99991	14	-9.5556	0.71398	0.99991	22	-14.937	0.85976	0.9829
"229"	"RNA polymerase"	9	-0.084765	0.59631	1	0.084765	0.40369	0.61563	-22.172	0.9999	0.99991	6	-20.109	0.9998	0.99991	3	-9.964	0.92062	0.9829
"230"	"RNA transport"	92	-6.625	1	1	6.625	2.1311e-08	6.4999e-06	-18.735	0.35525	0.8757	17	-18.408	0.98886	0.99991	75	-11.987	0.022805	0.41391
"231"	"Rap1 signaling pathway"	52	-2.5409	0.99339	1	2.5409	0.0066124	0.032529	-16.21	0.57494	0.99991	20	-13.125	0.84731	0.99991	32	-10.288	0.24324	0.66099
"232"	"Ras signaling pathway"	59	-2.3358	0.99348	1	2.3358	0.0065206	0.032529	-25.514	0.98854	0.99991	21	-20.703	0.99626	0.99991	38	-16.401	0.72459	0.94563
"233"	"Regulation of actin cytoskeleton"	97	-3.1588	0.99869	1	3.1588	0.0013075	0.014416	-18.589	0.26514	0.78983	35	-15.443	0.81006	0.99991	62	-11.649	0.055009	0.46466
"234"	"Regulation of lipolysis in adipocytes"	16	-0.7957	0.81944	1	0.7957	0.18056	0.33994	-13.792	0.89027	0.99991	6	-7.0081	0.68945	0.99991	10	-12.017	0.88366	0.9829
"235"	"Relaxin signaling pathway"	41	-1.5041	0.94533	1	1.5041	0.054671	0.13781	-14.631	0.5839	0.99991	18	-11.528	0.78033	0.99991	23	-9.3368	0.31523	0.6656
"236"	"Renal cell carcinoma"	30	-1.5305	0.94033	1	1.5305	0.059669	0.14444	-7.8973	0.18751	0.70604	10	-5.1797	0.38979	0.99991	20	-6.0096	0.14351	0.58527
"237"	"Renin secretion"	19	-4.2769	0.99978	1	4.2769	0.00022218	0.0042766	-4.5521	0.11925	0.55956	6	-7.6549	0.74039	0.99991	13	-0.30269	0.024793	0.41391
"238"	"Renin-angiotensin system"	11	-1.3922	0.90936	1	1.3922	0.090642	0.19607	-2.9881	0.16904	0.6967	5	-5.4584	0.57585	0.99991	6	0.93688	0.051001	0.46466
"239"	"Retinol metabolism"	9	0.84435	0.32638	1	-0.84435	0.67362	0.86325	-4.6628	0.35006	0.87516	6	-5.7694	0.58181	0.99991	3	0.083084	0.15233	0.58527
"240"	"Retrograde endocannabinoid signaling"	61	16.953	0	0	-16.953	1	1	11.152	2.0068e-11	8.7438e-10	48	13.49	2.4511e-09	1.0575e-07	13	-1.764	0.054671	0.46466
"241"	"Rheumatoid arthritis"	16	-1.2102	0.88968	1	1.2102	0.11032	0.2289	-11.038	0.72321	0.99991	5	-5.4272	0.57313	0.99991	11	-9.6527	0.69725	0.93822
"242"	"Riboflavin metabolism"	5	1.4149	0.19695	1	-1.4149	0.80305	0.9637	-2.0368	0.25794	0.78983	3	-2.5578	0.43196	0.99991	2	-0.08787	0.22095	0.66099
"243"	"Ribosome"	111	1.6649	0.36396	1	-1.6649	0.63604	0.82857	-5.1518	6.6766e-06	0.00018513	39	-1.6235	0.0081175	0.16343	72	-5.2018	0.00016729	0.04885
"244"	"Ribosome biogenesis in eukaryotes"	22	-0.40276	0.76113	1	0.40276	0.23887	0.41396	-16.034	0.91992	0.99991	5	-6.6165	0.67339	0.99991	17	-14.652	0.90218	0.9829
"245"	"SNARE interactions in vesicular transport"	18	-0.71989	0.79208	1	0.71989	0.20792	0.37747	-16.648	0.96513	0.99991	8	-13.038	0.95493	0.99991	10	-10.673	0.80187	0.9829
"246"	"Salivary secretion"	22	-1.7804	0.96167	1	1.7804	0.038331	0.1077	-9.7601	0.47081	0.95439	7	-4.3204	0.41658	0.99991	15	-8.8687	0.48147	0.80631
"247"	"Salmonella infection"	45	-1.3313	0.9284	1	1.3313	0.0716	0.16295	-12.698	0.3418	0.86351	19	-8.0707	0.48367	0.99991	26	-9.806	0.31555	0.6656
"248"	"Selenocompound metabolism"	9	1.6972	0.13858	0.88058	-1.6972	0.86142	1	0.18875	0.064354	0.43907	7	0.42938	0.10415	0.78635	2	-0.40291	0.2457	0.66099
"249"	"Serotonergic synapse"	26	-2.5494	0.99063	1	2.5494	0.0093699	0.040251	-10.133	0.42956	0.91549	12	-13.102	0.93153	0.99991	14	-1.6794	0.046825	0.46466
"250"	"Shigellosis"	39	-0.51323	0.7972	1	0.51323	0.2028	0.37261	-15.358	0.6832	0.99991	19	-14.097	0.89597	0.99991	20	-7.7066	0.26198	0.6656
"251"	"Signaling pathways regulating pluripotency of stem cells"	19	-2.3502	0.98236	1	2.3502	0.01764	0.064167	-10.945	0.64136	0.99991	6	-8.4806	0.79853	0.99991	13	-7.4699	0.4261	0.77819
"252"	"Small cell lung cancer"	34	1.4483	0.2534	1	-1.4483	0.7466	0.92192	-21.865	0.99031	0.99991	14	-8.0822	0.59217	0.99991	20	-21.747	0.99813	0.99894
"253"	"Sphingolipid metabolism"	7	0.44799	0.45252	1	-0.44799	0.54748	0.74834	-14.291	0.97744	0.99991	5	-13.659	0.97822	0.99991	2	-5.1388	0.70131	0.93822
"254"	"Sphingolipid signaling pathway"	45	-2.1364	0.97859	1	2.1364	0.021405	0.073355	-17.526	0.75961	0.99991	13	-13.524	0.94074	0.99991	32	-12.164	0.40956	0.76173
"255"	"Spliceosome"	94	-2.5279	0.99582	1	2.5279	0.0041825	0.024069	-33.764	0.9993	0.99991	21	-15.567	0.93457	0.99991	73	-29.965	0.9967	0.99894
"256"	"Staphylococcus aureus infection"	15	-2.5911	0.98692	1	2.5911	0.013083	0.053194	-7.3106	0.43949	0.91877	3	-5.6964	0.7075	0.99991	12	-5.3253	0.25579	0.66099
"257"	"Starch and sucrose metabolism"	19	1.3722	0.26984	1	-1.3722	0.73016	0.90898	-2.6515	0.05083	0.39752	11	-2.0832	0.17131	0.99492	8	-1.6435	0.10185	0.54073
"258"	"Steroid biosynthesis"	6	1.3728	0.20066	1	-1.3728	0.79934	0.9637	-9.3354	0.84655	0.99991	6	-9.3354	0.84966	0.99991	0			
"259"	"Steroid hormone biosynthesis"	6	1.9244	0.10603	0.78875	-1.9244	0.89397	1	-1.584	0.20689	0.74193	3	2.6291	0.087379	0.73302	3	-4.8691	0.5691	0.82115
"260"	"Sulfur metabolism"	6	3.9802	0.0027943	0.030438	-3.9802	0.99721	1	2.2265	0.042598	0.34191	6	2.2265	0.049358	0.55208	0			
"261"	"Sulfur relay system"	6	2.8281	0.02759	0.2475	-2.8281	0.97241	1	-1.2876	0.18738	0.70604	4	-0.77764	0.24156	0.99991	2	-1.1304	0.30809	0.6656
"262"	"Synaptic vesicle cycle"	24	-2.8512	0.99438	1	2.8512	0.005625	0.030098	-8.4324	0.31966	0.84807	4	-9.4146	0.88353	0.99991	20	-5.0269	0.094723	0.54073
"263"	"Synthesis and degradation of ketone bodies"	8	4.5177	0.00095701	0.011676	-4.5177	0.99904	1	-2.0072	0.18338	0.70604	8	-2.0072	0.22071	0.99991	0			
"264"	"Systemic lupus erythematosus"	22	-3.0616	0.99708	1	3.0616	0.0029197	0.020133	-9.2961	0.42759	0.91549	5	-5.485	0.57817	0.99991	17	-7.6005	0.31899	0.6656
"265"	"T cell receptor signaling pathway"	36	-3.3185	0.99794	1	3.3185	0.0020624	0.017473	-15.223	0.69878	0.99991	11	-11.357	0.86181	0.99991	25	-10.734	0.42641	0.77819
"266"	"TGF-beta signaling pathway"	15	-1.3341	0.90449	1	1.3341	0.095507	0.2037	-11.946	0.82349	0.99991	3	-10.5	0.94992	0.99991	12	-8.1064	0.51488	0.80631
"267"	"TNF signaling pathway"	26	-0.8183	0.85467	1	0.8183	0.14533	0.28782	-20.3	0.98793	0.99991	12	-13.773	0.94963	0.99991	14	-14.913	0.94709	0.98768
"268"	"Taste transduction"	2	-0.74754	0.73837	1	0.74754	0.26163	0.44579	-5.4146	0.71159	0.99991	0				2	-5.4146	0.72542	0.94563
"269"	"Taurine and hypotaurine metabolism"	2	0.62524	0.36225	1	-0.62524	0.63775	0.82857	-5.5826	0.72495	0.99991	2	-5.5826	0.72739	0.99991	0			
"270"	"Terpenoid backbone biosynthesis"	15	1.8805	0.15025	0.93525	-1.8805	0.84975	1	-8.7138	0.56944	0.99991	12	-7.8063	0.60732	0.99991	3	-3.872	0.47304	0.80631
"271"	"Th1 and Th2 cell differentiation"	22	-2.6067	0.99195	1	2.6067	0.0080538	0.036124	-10.486	0.53897	0.99991	9	-8.9717	0.77512	0.99991	13	-6.1766	0.30608	0.6656
"272"	"Th17 cell differentiation"	28	-3.1142	0.99715	1	3.1142	0.0028517	0.020133	-10.47	0.4278	0.91549	11	-10.603	0.82195	0.99991	17	-4.9077	0.12623	0.58527
"273"	"Thermogenesis"	132	25.722	0	0	-25.722	1	1	11.208	0	0	112	16.372	0	0	20	-9.949	0.47112	0.80631
"274"	"Thiamine metabolism"	7	1.9195	0.11257	0.81751	-1.9195	0.88743	1	-0.88875	0.11493	0.55499	5	-1.3445	0.23413	0.99991	2	0.4631	0.18128	0.63776
"275"	"Thyroid cancer"	11	-1.525	0.92455	1	1.525	0.075446	0.16796	-4.951	0.31867	0.84807	5	-5.2746	0.55975	0.99991	6	-1.8887	0.17821	0.63459
"276"	"Thyroid hormone signaling pathway"	42	-1.8068	0.97513	1	1.8068	0.024866	0.082435	-15.332	0.63821	0.99991	16	-10.923	0.75124	0.99991	26	-10.918	0.42336	0.77819
"277"	"Thyroid hormone synthesis"	21	-0.6599	0.81635	1	0.6599	0.18365	0.34365	-4.9102	0.11427	0.55499	11	-3.5293	0.26393	0.99991	10	-3.414	0.15456	0.58613
"278"	"Tight junction"	80	-1.9335	0.98675	1	1.9335	0.013255	0.053194	-22.531	0.80324	0.99991	35	-16.84	0.8821	0.99991	45	-15.19	0.45995	0.80631
"279"	"Toll-like receptor signaling pathway"	29	-1.3272	0.91957	1	1.3272	0.080434	0.17649	-18.345	0.94151	0.99991	12	-13.199	0.93441	0.99991	17	-12.87	0.80186	0.9829
"280"	"Toxoplasmosis"	41	0.5301	0.54784	1	-0.5301	0.45216	0.66303	-14.012	0.52692	0.99991	20	-8.1963	0.45989	0.99991	21	-11.58	0.61369	0.8574
"281"	"Transcriptional misregulation in cancer"	23	-0.62475	0.80616	1	0.62475	0.19384	0.35832	-25.019	0.99991	0.99991	10	-18.161	0.9956	0.99991	13	-17.35	0.9882	0.99894
"282"	"Tryptophan metabolism"	21	5.6621	4.5207e-05	0.00065658	-5.6621	0.99995	1	0.023832	0.0091856	0.13944	19	-0.59208	0.049045	0.55208	2	1.9021	0.10026	0.54073
"283"	"Tuberculosis"	54	-2.492	0.9939	1	2.492	0.006105	0.03156	-15.671	0.49723	0.97214	15	-6.577	0.4307	0.99991	39	-14.362	0.46886	0.80631
"284"	"Type I diabetes mellitus"	5	1.5576	0.16976	1	-1.5576	0.83024	0.98915	-7.1784	0.72573	0.99991	3	-3.3046	0.49973	0.99991	2	-7.3027	0.8608	0.9829
"285"	"Type II diabetes mellitus"	18	0.63393	0.43547	1	-0.63393	0.56453	0.75518	-13.608	0.86354	0.99991	9	-5.5326	0.48824	0.99991	9	-13.713	0.95675	0.99068
"286"	"Tyrosine metabolism"	13	2.3043	0.089792	0.7207	-2.3043	0.91021	1	0.26175	0.028894	0.3121	8	0.065907	0.1088	0.80137	5	0.33869	0.077566	0.51269
"287"	"Ubiquinone and other terpenoid-quinone biosynthesis"	6	3.3197	0.011255	0.11443	-3.3197	0.98874	1	-3.9306	0.39723	0.91093	5	-0.63435	0.18848	0.99991	1	-8.2095	0.92732	0.9829
"288"	"Ubiquitin mediated proteolysis"	51	-3.0996	0.99844	1	3.0996	0.00156	0.01586	-21.486	0.92945	0.99991	10	-7.0119	0.55149	0.99991	41	-20.501	0.92403	0.9829
"289"	"VEGF signaling pathway"	28	-3.57	0.99903	1	3.57	0.00096572	0.012273	-10.944	0.47438	0.95439	9	-12.116	0.92972	0.99991	19	-4.9468	0.10052	0.54073
"290"	"Valine, leucine and isoleucine degradation"	41	13.503	0	0	-13.503	1	1	7.1456	5.5967e-07	1.8966e-05	39	7.2332	4.2504e-06	0.00012836	2	0.41207	0.18475	0.64065
"291"	"Vascular smooth muscle contraction"	40	-3.4323	0.99887	1	3.4323	0.0011285	0.013768	-9.9954	0.19867	0.73897	11	-9.0078	0.71646	0.99991	29	-6.1913	0.056263	0.46466
"292"	"Vasopressin-regulated water reabsorption"	22	-3.6311	0.9993	1	3.6311	0.00069914	0.0092713	-4.0331	0.077492	0.45452	2	-0.89213	0.3405	0.99991	20	-3.9478	0.056596	0.46466
"293"	"Vibrio cholerae infection"	21	-1.5086	0.9392	1	1.5086	0.060798	0.14601	-7.168	0.2495	0.78983	7	-4.4566	0.42835	0.99991	14	-5.6276	0.24391	0.66099
"294"	"Viral carcinogenesis"	66	-2.7739	0.99689	1	2.7739	0.0031149	0.020133	-18.968	0.66604	0.99991	16	-13.336	0.89034	0.99991	50	-14.249	0.32325	0.6656
"295"	"Viral myocarditis"	25	-3.0495	0.99532	1	3.0495	0.0046809	0.025958	-5.136	0.081329	0.45936	7	-7.8121	0.71209	0.99991	18	-1.1812	0.015907	0.41391
"296"	"Vitamin B6 metabolism"	3	-0.11114	0.60394	1	0.11114	0.39606	0.60703	-1.724	0.32707	0.84807	2	-2.3087	0.45849	0.99991	1	0.27891	0.25525	0.66099
"297"	"Vitamin digestion and absorption"	5	-0.85259	0.78124	1	0.85259	0.21876	0.38792	-4.1422	0.44512	0.92355	1	-1.0486	0.42006	0.99991	4	-4.1068	0.45808	0.80631
"298"	"Wnt signaling pathway"	37	-4.0014	0.99976	1	4.0014	0.00023837	0.0042766	-12.819	0.47858	0.95439	7	-11.88	0.9274	0.99991	30	-8.4974	0.14269	0.58527
"299"	"alpha-Linolenic acid metabolism"	4	0.93718	0.3167	1	-0.93718	0.6833	0.86836	-7.0857	0.74438	0.99991	3	-8.1649	0.86658	0.99991	1	-0.029408	0.28053	0.6656
"300"	"beta-Alanine metabolism"	18	4.6457	0.0011251	0.013199	-4.6457	0.99887	1	-1.0883	0.031557	0.3121	15	-1.6076	0.10123	0.78391	3	0.92897	0.10906	0.56865
"301"	"cAMP signaling pathway"	56	-3.3218	0.99874	1	3.3218	0.001261	0.014416	-15.575	0.47081	0.95439	14	-7.7771	0.5653	0.99991	42	-13.494	0.3473	0.68463
"302"	"cGMP-PKG signaling pathway"	56	-2.585	0.99358	1	2.585	0.006417	0.032529	-6.8245	0.013054	0.18097	19	-3.508	0.15264	0.94545	37	-5.882	0.020041	0.41391
"303"	"mRNA surveillance pathway"	43	-1.7824	0.96942	1	1.7824	0.030578	0.091631	-21.533	0.96767	0.99991	11	-11.808	0.88251	0.99991	32	-18.038	0.89156	0.9829
"304"	"mTOR signaling pathway"	59	-3.3149	0.99939	1	3.3149	0.00060751	0.008728	-18.746	0.73716	0.99991	22	-20.078	0.99274	0.99991	37	-8.1895	0.070307	0.51269
"305"	"p53 signaling pathway"	11	0.92705	0.34376	1	-0.92705	0.65624	0.8481	-12.227	0.90861	0.99991	3	-2.9722	0.46945	0.99991	8	-12.518	0.94233	0.98624
